WCM
AGIO icon

Weld Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Weld Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,052
Closed -$948K – 712
2019
Q1 		$948K Buy
+14,052
New +$818K 0.17% 223

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Weld Capital Management's AGIO Position: Q2 2019 in Review

Weld Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2019, closing a stake of 14,052 shares — an estimated $948K sold.

Weld Capital Management first reported a position in AGIO in Q1 2019 and held it in 1 quarter. The position peaked at $948K in Q1 2019. 189 funds tracked by Wall St. Rank hold AGIO as of Q2 2019.

  • Weld Capital Management reported no remaining Agios Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Weld Capital Management sold 14,052 Agios Pharmaceuticals shares in Q2 2019, an estimated $948K.
  • Weld Capital Management first reported a position in Agios Pharmaceuticals in Q1 2019 and held it in 1 quarter.
  • Weld Capital Management's Agios Pharmaceuticals position peaked at $948K in Q1 2019.
  • 189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2019.

Based on Weld Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.